These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31678403)

  • 1. Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome.
    Hamlett ED; Ledreux A; Gilmore A; Vazey EM; Aston-Jones G; Boger HA; Paredes D; Granholm AE
    Neurobiol Dis; 2020 Feb; 134():104616. PubMed ID: 31678403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designer receptors enhance memory in a mouse model of Down syndrome.
    Fortress AM; Hamlett ED; Vazey EM; Aston-Jones G; Cass WA; Boger HA; Granholm AC
    J Neurosci; 2015 Jan; 35(4):1343-53. PubMed ID: 25632113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model.
    Lockrow J; Boger H; Gerhardt G; Aston-Jones G; Bachman D; Granholm AC
    J Alzheimers Dis; 2011; 23(3):471-89. PubMed ID: 21098982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
    Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
    Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG
    J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clozapine-N-oxide and compound 21 on sleep in laboratory mice.
    Traut J; Mengual JP; Meijer EJ; McKillop LE; Alfonsa H; Hoerder-Suabedissen A; Song SH; Fehér KD; Riemann D; Molnar Z; Akerman CJ; Vyazovskiy VV; Krone LB
    Elife; 2023 Mar; 12():. PubMed ID: 36892930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the Locus Coeruleus Mediated by Designer Receptor Exclusively Activated by Designer Drug Restores Descending Nociceptive Inhibition after Traumatic Brain Injury in Rats.
    Irvine KA; Peters CM; Vazey EM; Ferguson AR; Clark JD
    J Neurotrauma; 2022 Jul; 39(13-14):964-978. PubMed ID: 35412843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.
    Faizi M; Bader PL; Tun C; Encarnacion A; Kleschevnikov A; Belichenko P; Saw N; Priestley M; Tsien RW; Mobley WC; Shamloo M
    Neurobiol Dis; 2011 Aug; 43(2):397-413. PubMed ID: 21527343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Retrieval of Taste Associative Memory by Chemogenetic Activation of Locus Coeruleus Norepinephrine Neurons.
    Fukabori R; Iguchi Y; Kato S; Takahashi K; Eifuku S; Tsuji S; Hazama A; Uchigashima M; Watanabe M; Mizuma H; Cui Y; Onoe H; Hikishima K; Yasoshima Y; Osanai M; Inagaki R; Fukunaga K; Nishijo T; Momiyama T; Benton R; Kobayashi K
    J Neurosci; 2020 Oct; 40(43):8367-8385. PubMed ID: 32994339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys.
    Upright NA; Brookshire SW; Schnebelen W; Damatac CG; Hof PR; Browning PGF; Croxson PL; Rudebeck PH; Baxter MG
    J Neurosci; 2018 Sep; 38(37):7969-7975. PubMed ID: 30082415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of noradrenergic terminals in the reticular thalamus delays arousal from propofol anesthesia in mice.
    Zhang Y; Fu B; Liu C; Yu S; Luo T; Zhang L; Zhou W; Yu T
    FASEB J; 2019 Jun; 33(6):7252-7260. PubMed ID: 30860868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of locus coeruleus-spinal cord noradrenergic neurons alleviates neuropathic pain in mice via reducing neuroinflammation from astrocytes and microglia in spinal dorsal horn.
    Li J; Wei Y; Zhou J; Zou H; Ma L; Liu C; Xiao Z; Liu X; Tan X; Yu T; Cao S
    J Neuroinflammation; 2022 May; 19(1):123. PubMed ID: 35624514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.
    Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC
    Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of amyloid beta peptides to locus coeruleus and medial prefrontal cortex in corticotropin releasing factor overexpressing male and female mice.
    Ross JA; Alexis R; Reyes BAS; Risbrough V; Van Bockstaele EJ
    Brain Struct Funct; 2019 Sep; 224(7):2385-2405. PubMed ID: 31250157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.
    Gomez JL; Bonaventura J; Lesniak W; Mathews WB; Sysa-Shah P; Rodriguez LA; Ellis RJ; Richie CT; Harvey BK; Dannals RF; Pomper MG; Bonci A; Michaelides M
    Science; 2017 Aug; 357(6350):503-507. PubMed ID: 28774929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G
    Marciante AB; Farmer GE; Cunningham JT
    J Neurophysiol; 2020 Aug; 124(2):591-609. PubMed ID: 32697679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease.
    Braun D; Feinstein DL
    Brain Res; 2019 Jan; 1702():29-37. PubMed ID: 29274883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Feasibility Study to Investigate Chemogenetic Modulation of the Locus Coeruleus by Means of Single Unit Activity.
    Stevens L; Vonck K; Larsen LE; Van Lysebettens W; Germonpré C; Baekelandt V; Van den Haute C; Carrette E; Wadman WJ; Boon P; Raedt R
    Front Neurosci; 2020; 14():162. PubMed ID: 32210746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.
    Hou L; Qu X; Qiu X; Huang R; Zhao X; Wang Q
    J Neuroinflammation; 2020 May; 17(1):148. PubMed ID: 32375810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.